These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22311781)

  • 1. Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee.
    Birnie DH; Parkash R; Exner DV; Essebag V; Healey JS; Verma A; Coutu B; Kus T; Mangat I; Ayala-Paredes F; Nery P; Wells G; Krahn AD
    Circulation; 2012 Mar; 125(10):1217-25. PubMed ID: 22311781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
    Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
    Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of fracture risk of a small caliber implantable cardioverter defibrillator lead.
    Ha AC; Vezi BZ; Keren A; Alanazi H; Gollob MH; Green MS; Lemery R; Nery PB; Posan E; Birnie DH
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):437-43. PubMed ID: 19954500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure.
    Da Costa A; Da Cruz C; Romeyer-Bouchard C; Abdellaoui L; Nadrouss A; Bisch L; Chometon F; Afif Z; Gate-Martinet A; Combier M; Isaaz K
    Arch Cardiovasc Dis; 2012 Apr; 105(4):203-10. PubMed ID: 22633294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Fidelis lead survival: transition from an exponential to linear pattern of lead failure over time.
    Cheung JW; Tobin-Hess A; Patel A; Slotwiner DJ; Goldner BG
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):906-12. PubMed ID: 22923271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent risk of Fidelis lead failure.
    Faulknier BA; Traub DM; Aktas MK; Aguila A; Rosero S; Daubert JP; Hall B; Shah A; Taylor S; McNitt S; Moss AJ; Zareba W; Huang DT
    Am J Cardiol; 2010 Jan; 105(1):95-9. PubMed ID: 20102898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right-sided implantation and subpectoral position are predisposing factors for fracture of a 6.6 French ICD lead.
    Bernstein NE; Karam ET; Aizer A; Wong BC; Holmes DS; Bernstein SA; Chinitz LA
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):659-64. PubMed ID: 22469148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sprint Fidelis lead fractures in patients with cardiac resynchronization therapy devices: insight from the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) study.
    Parkash R; Thibault B; Sterns L; Sapp J; Krahn A; Talajic M; Luce M; Yetisir E; Theoret-Patrick P; Wells G; Tang A
    Circulation; 2012 Dec; 126(25):2928-34. PubMed ID: 23159551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee.
    Parkash R; Crystal E; Bashir J; Simpson C; Birnie D; Sterns L; Exner D; Thibault B; Connors S; Healey JS; Champagne J; Cameron D; Mangat I; Verma A; Wolfe K; Essebag V; Kus T; Ayala-Paredes F; Davies T; Sanatani S; Gow R; Coutu B; Sivakumaran S; Stephenson E; Krahn A
    Circulation; 2010 Jun; 121(22):2384-7. PubMed ID: 20497979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive-fixation lead failure rates and long-term patient mortality in subjects implanted with Sprint Fidelis electrodes.
    Vollmann D; Woronowicz S; Kmiec L; Jung K; Zenker D; Seegers J; Sossalla S; Dorenkamp M; Sohns C; Lüthje L; Hasenfuss G; Zabel M
    Europace; 2014 Feb; 16(2):258-64. PubMed ID: 23813451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
    Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of implanted recalled sprint Fidelis lead on patient mortality.
    Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG
    J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating risk of Fidelis lead fracture.
    Farwell D; Green MS; Lemery R; Gollob MH; Birnie DH
    Heart Rhythm; 2008 Oct; 5(10):1375-9. PubMed ID: 18783996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management.
    Hauser RG; Maisel WH; Friedman PA; Kallinen LM; Mugglin AS; Kumar K; Hodge DO; Morrison TB; Hayes DL
    Circulation; 2011 Feb; 123(4):358-63. PubMed ID: 21242478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of implantable cardioverter-defibrillator leads: a matter of lead size?
    Rordorf R; Poggio L; Savastano S; Vicentini A; Petracci B; Chieffo E; Klersy C; Landolina M
    Heart Rhythm; 2013 Feb; 10(2):184-90. PubMed ID: 23063430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.
    Fazal IA; Shepherd EJ; Tynan M; Plummer CJ; McComb JM
    Int J Cardiol; 2013 Sep; 168(2):848-52. PubMed ID: 23138013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of lead safety recommendations.
    VAN Rees JB; Borleffs CJ; Bax JJ; Nagtegaal EM; VAN DER Velde ET; VAN Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):431-6. PubMed ID: 19954503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generator exchange is associated with an increased rate of Sprint Fidelis lead failure.
    Lovelock JD; Patel A; Mengistu A; Hoskins M; El-Chami M; Lloyd MS; Leon A; DeLurgio D; Langberg JJ
    Heart Rhythm; 2012 Oct; 9(10):1615-8. PubMed ID: 22683747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.